Nathan Caffo

No open positions remaining

57 year

Health Technology

Consumer Services

Profile

Nathan Caffo served as the President & Chief Executive Officer at Presage Biosciences, Inc. from 2009 to 2018.
He then worked as the Chief Business Officer at ALX Oncology Holdings, Inc. from 2018 to 2020.
Currently, he is the Chief Business Officer at Candel Therapeutics, Inc. starting from 2020.
Mr. Caffo completed his undergraduate degree at The Pennsylvania State University.

Former positions of Nathan Caffo

Companies	Position	End
CANDEL THERAPEUTICS, INC.	Corporate Officer/Principal	01/04/2023
ALX ONCOLOGY HOLDINGS INC.	Corporate Officer/Principal	01/09/2020
Presage Biosciences, Inc. Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of novel drugs for treatment of cancers	Chief Executive Officer	17/07/2018

See the detail of Nathan Caffo's experience

Training of Nathan Caffo

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nathan Caffo's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Presage Biosciences, Inc. Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of novel drugs for treatment of cancers	Health Technology
The Pennsylvania State University The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Candel Therapeutics, Inc. Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer	Health Technology
ALX Oncology Holdings, Inc. ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer	Health Technology